Detalhe da pesquisa
1.
Evidence of myeloid differentiation in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene.
Cancer Biol Ther
; 6(1): 18-21, 2007 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-17204865